DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Strain WD, Lukashevich V2 Kothny W. et al.
Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study.
Lancet 2013;
382: 409-416
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.